A phase 3 open-label, randomized multicenter study to evaluate efficacy and safety of secukinumab in pediatric patients with moderate to severe plaque psoriasis: 24-week results-Reference-Cited by-同舟云学术

A phase 3 open-label, randomized multicenter study to evaluate efficacy and safety of secukinumab in pediatric patients with moderate to severe plaque psoriasis: 24-week results

Published:2022-01 Issue:1 Volume:86 Page:122-130
ISSN:0190-9622
Container-title:Journal of the American Academy of Dermatology
language:en
Short-container-title:Journal of the American Academy of Dermatology

Author:

Magnolo Nina,Kingo Külli,Laquer Vivian,Browning John,Reich Adam,Szepietowski Jacek C.,Keefe Deborah,Mazur Rafal,Ghelani Prayashi,Forrer Pascal,Wraith LindaAnn,Patekar Manmath

Funder

Novartis

Publisher

Elsevier BV

Subject

Dermatology

Reference39 articles.

1. The epidemiology of childhood psoriasis: a scoping review;Burden-Teh;Br J Dermatol,2016

2. Pediatric psoriasis: evolving perspectives;Eichenfield;Pediatr Dermatol,2018

3. Systemic treatment of pediatric psoriasis: a review;Napolitano;Dermatol Ther (Heidelb),2016

4. Prevalence of psoriasis in children and adolescents in the United States: a claims-based analysis;Paller;J Drugs Dermatol,2018

5. Childhood psoriasis;Mahé;Eur J Dermatol,2016

Cited by 28 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Clinical efficacy and safety of secukinumab in the treatment of generalized pustular psoriasis in the pediatric population: a systematic review of the literature;Frontiers in Medicine;2024-08-09

2. A Randomized, Double-Blind, Parallel-Group Phase I Study Comparing the Pharmacokinetics, Safety, and Immunogenicity of CMAB015, a Candidate Secukinumab Biosimilar, with Its Reference Product Cosentyx® in Healthy Chinese Male Subjects;Drug Design, Development and Therapy;2024-08

3. Therapeutic management of infantile digital fibromatosis;Italian Journal of Dermatology and Venereology;2024-07

4. Evolving Landscape of Biologic Therapy for Pediatric Psoriasis;Dermatologic Clinics;2024-07

5. A new light on secukinumab in pediatric psoriasis;Italian Journal of Dermatology and Venereology;2024-07